A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Trial details
- Registry ID
- NCT07160634
- Drugs studied
- SGT-003
TrialRedline tracks 1 clinical trial sponsored by Solid Biosciences Inc.: 1 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)NCT07160634 | SGT-003 | Recruiting | 2029-01Estimated |
Names as written in the registry records.
NCT07160634 · Solid Biosciences Inc.
Before: Not yet recruiting. After: Recruiting.